NovaVive Inc. - Equine

NovaVive Inc. - Equine NovaVive offers regulator-approved equine immunotherapies in the USA, Canada, UAE, Australia and NZ. NovaVive Inc.

is an animal health immunobiology company with regulator-approved horse products available to veterinarians in CA, US, AU, and NZ.

Endometritis is a significant cause of reduced fertility in broodmares and is commonly associated with impaired uterine ...
05/29/2026

Endometritis is a significant cause of reduced fertility in broodmares and is commonly associated with impaired uterine clearance mechanisms.

Mares susceptible to persistent post-breeding endometritis (PPBE) are unable to resolve inflammation within the normal 48-hour window following breeding, increasing the risk of embryonic loss.

Settle® is indicated as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus and may be administered as part of a veterinarian-directed reproductive management protocol.

Explore the full product brochure at NovaVive.ca/products.

Recent reports of EHV-1 are a reminder of how quickly respiratory disease can spread when horses gather.Equimune® is a U...
05/27/2026

Recent reports of EHV-1 are a reminder of how quickly respiratory disease can spread when horses gather.

Equimune® is a USDA-approved immunotherapeutic for the treatment of Equine Respiratory Disease Complex (ERDC) of viral origin.

Consult your veterinarian for appropriate use and learn more at NovaVive.ca/products

Equine sarcoids are locally aggressive fibroblastic tumors frequently associated with bovine papillomavirus (BPV) infect...
05/24/2026

Equine sarcoids are locally aggressive fibroblastic tumors frequently associated with bovine papillomavirus (BPV) infection.

Immunocidin® Equine (MCWF immunostimulant) is administered by intratumoral injection and stimulates a localized immune response.

Treatment may be repeated at regular intervals depending on tumor size and clinical response, as determined by a veterinarian.

Contact NovaVive – [email protected] – for more information about sarcoid treatment with Immunocidin Equine.

NovaVive manufactures immunotherapy products for horses, cattle, and dogs—supporting veterinarians with immune-based too...
05/21/2026

NovaVive manufactures immunotherapy products for horses, cattle, and dogs—supporting veterinarians with immune-based tools across a range of clinical applications.

Our equine portfolio includes Equimune® (U.S., Australia, New Zealand) and Settle® (U.S., Canada, Australia, New Zealand, UAE), along with Immunocidin® Equine, available in the U.S. and Canada.

For bovine use, Amplimune® is available in the U.S., Canada, New Zealand, and the UAE.

In canine applications, Immunocidin® is approved for use in the U.S. and Canada.

From performance horses to newborn calves to companion animals, NovaVive’s approach is rooted in advancing animal health through immunology.

Discover more at NovaVive.ca/products.

Effective reproductive management requires timely intervention aligned with the mare’s estrous cycle.Settle® may be admi...
05/19/2026

Effective reproductive management requires timely intervention aligned with the mare’s estrous cycle.

Settle® may be administered during early estrous, at the time of diagnosis of uterine infection, or in mares identified as high-risk for endometritis.

Its use is often incorporated into breeding programs to support uterine health, particularly in mares with a history of reproductive challenges and is approved for use in the USA, Canada, Australia, New Zealand, and the UAE.

Read more at NovaVive.ca/products

Shows and events bring horses into close contact conditions where EHV-1 and other viruses may spread more easily.Equimun...
05/18/2026

Shows and events bring horses into close contact conditions where EHV-1 and other viruses may spread more easily.

Equimune® is approved for the treatment of Equine Respiratory Disease Complex (ERDC) of viral origin and may be incorporated into management protocols under veterinary guidance.

Read more in the product brochure at NovaVive.ca/products.

Equine sarcoids are the most common skin tumors in horses.In one study using mycobacterium cell wall fraction (MCWF), 73...
05/15/2026

Equine sarcoids are the most common skin tumors in horses.

In one study using mycobacterium cell wall fraction (MCWF), 73% of cases experienced complete regression and 27% showed partial regression (data on file).

Immunocidin® Equine is a USDA-approved immunother apeutic for the treatment of equine sarcoid tumors and is administered by intratumoral injection under veterinary supervision.

Learn more and read the full product brochure at NovaVive.ca/products.

Equine respiratory disease complex (ERDC) remains a key concern in performance horses, especially in environments where ...
05/07/2026

Equine respiratory disease complex (ERDC) remains a key concern in performance horses, especially in environments where horses frequently interact with new populations.

Equimune® is designed to stimulate both innate and specific immune responses, supporting the horse’s ability to respond to viral respiratory challenges.

Its mechanism includes activation of antigen-presenting cells and downstream immune signaling pathways involved in early defense against viral pathogens.

View product details and supporting materials at NovaVive.ca/products.

Across equine, bovine, and canine health, immune system function plays a critical role in how animals respond to disease...
04/27/2026

Across equine, bovine, and canine health, immune system function plays a critical role in how animals respond to disease challenges, environmental stressors, and management conditions.

NovaVive’s immunotherapeutics are developed using a proprietary mycobacterium cell wall fraction (MCWF) derived from Mycobacterium phlei, a non-pathogenic organism. This technology is designed to activate key components of the immune system, including macrophages and lymphocytes, supporting both innate and adaptive immune responses.

With applications across multiple species, NovaVive products provide veterinarians and producers with additional tools to support animal health through immune system activation.

Explore our full regulator-approved product portfolio and supporting information at NovaVive.ca/products.

Stressors such as hauling, competition, heat, and changing routines can influence immune system responsiveness in horses...
04/22/2026

Stressors such as hauling, competition, heat, and changing routines can influence immune system responsiveness in horses, particularly during warmer months.

Equimune® has been shown to stimulate mononuclear cells, including macrophages and lymphocytes, supporting immune activity for several days following administration.

Administered intravenously by a veterinarian, it is often used during periods of increased exposure or upon first signs of respiratory disease.

Learn more at NovaVive.ca/products.

Address

15 Dairy Avenue
Napanee, ON
K7R1M4

Telephone

1-613-308-9788

Website

Alerts

Be the first to know and let us send you an email when NovaVive Inc. - Equine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to NovaVive Inc. - Equine:

Shortcuts

Share